385 related articles for article (PubMed ID: 31707235)
1. The frequency of longitudinally extensive transverse myelitis in MS: A population-based study.
Asnafi S; Morris PP; Sechi E; Pittock SJ; Weinshenker BG; Palace J; Messina S; Flanagan EP
Mult Scler Relat Disord; 2020 Jan; 37():101487. PubMed ID: 31707235
[TBL] [Abstract][Full Text] [Related]
2. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
3. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
Dubey D; Pittock SJ; Krecke KN; Morris PP; Sechi E; Zalewski NL; Weinshenker BG; Shosha E; Lucchinetti CF; Fryer JP; Lopez-Chiriboga AS; Chen JC; Jitprapaikulsan J; McKeon A; Gadoth A; Keegan BM; Tillema JM; Naddaf E; Patterson MC; Messacar K; Tyler KL; Flanagan EP
JAMA Neurol; 2019 Mar; 76(3):301-309. PubMed ID: 30575890
[TBL] [Abstract][Full Text] [Related]
4. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.
Cobo-Calvo Á; Sepúlveda M; Bernard-Valnet R; Ruiz A; Brassat D; Martínez-Yélamos S; Saiz A; Marignier R
Mult Scler; 2016 Mar; 22(3):312-9. PubMed ID: 26209592
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children.
Tantsis EM; Prelog K; Alper G; Benson L; Gorman M; Lim M; Mohammad SS; Ramanathan S; Brilot F; Dale RC;
Dev Med Child Neurol; 2019 Sep; 61(9):1108-1116. PubMed ID: 30537075
[TBL] [Abstract][Full Text] [Related]
8. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
[TBL] [Abstract][Full Text] [Related]
9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
10. MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation.
Loos J; Pfeuffer S; Pape K; Ruck T; Luessi F; Spreer A; Zipp F; Meuth SG; Bittner S
J Neurol; 2020 Jun; 267(6):1632-1642. PubMed ID: 32055995
[TBL] [Abstract][Full Text] [Related]
11. Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS.
Etemadifar M; Salari M; Etemadifar MR; Sabeti F; Fateh ST; Aminzade Z
Mult Scler Relat Disord; 2022 Apr; 60():103664. PubMed ID: 35219242
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP
Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487
[TBL] [Abstract][Full Text] [Related]
13. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
Maillart E; Durand-Dubief F; Louapre C; Audoin B; Bourre B; Derache N; Ciron J; Collongues N; de Sèze J; Cohen M; Lebrun-Frenay C; Hadhoum N; Zéphir H; Deschamps R; Carra-Dallière C; Labauge P; Kerschen P; Montcuquet A; Wiertlewski S; Laplaud D; Runavot G; Vukusic S; Papeix C; Marignier R;
J Neuroinflammation; 2020 Apr; 17(1):128. PubMed ID: 32326965
[TBL] [Abstract][Full Text] [Related]
14. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
[TBL] [Abstract][Full Text] [Related]
15. MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting.
Bilodeau PA; Kumar V; Rodriguez AE; Li CT; Sanchez-Alvarez C; Thanarajasingam U; Zalewski NL; Flanagan EP
Mult Scler; 2020 Jul; 26(8):997-1000. PubMed ID: 31621483
[TBL] [Abstract][Full Text] [Related]
16. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
17. Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
Iorio R; Damato V; Mirabella M; Evoli A; Marti A; Plantone D; Frisullo G; Batocchi AP
J Neurol; 2013 Sep; 260(9):2396-402. PubMed ID: 23793787
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
Lechner C; Baumann M; Hennes EM; Schanda K; Marquard K; Karenfort M; Leiz S; Pohl D; Venkateswaran S; Pritsch M; Koch J; Schimmel M; Häusler M; Klein A; Blaschek A; Thiels C; Lücke T; Gruber-Sedlmayr U; Kornek B; Hahn A; Leypoldt F; Sandrieser T; Gallwitz H; Stoffels J; Korenke C; Reindl M; Rostásy K
J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):897-905. PubMed ID: 26645082
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.
Sechi E; Shosha E; Williams JP; Pittock SJ; Weinshenker BG; Keegan BM; Zalewski NL; Lopez-Chiriboga AS; Jitprapaikulsan J; Flanagan EP
Neurology; 2019 Jul; 93(4):e414-e420. PubMed ID: 31235660
[TBL] [Abstract][Full Text] [Related]
20. Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study.
Chen C; Liu C; Fang L; Zou Y; Ruan H; Wang Y; Cui C; Sun X; Peng L; Qiu W
J Neurol Sci; 2019 Oct; 405():116430. PubMed ID: 31465985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]